Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway

TSAI-KUN WUYEN-CHUAN OUYI-PING CHENFU-MEI HUANGYING-RU PANCHIA-JEN LEE2026-01-282026-01-282021-07-1910.21873/anticanres.15171https://scholars.csmu.edu.tw/handle/123456789/3213[SDGs]SDG3Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathwayjournal-article